Elevated Plasma Homocysteine Levels and Risk of Silent Brain Infarction in Elderly People

Background and Purpose Silent brain infarction (SBI) on MRI is common in elderly people, and recent studies have demonstrated that SBI increases the risk of progression to clinically apparent stroke and cognitive decline. Therefore, an early and accurate detection of SBI and a search for potential treatable risk factors may have a significant impact on public health. Methods Community-dwelling elderly people aged ≥66 years who participated in the present study (n=153) underwent brain MRI and standardized physical and neuropsychological examinations as well as blood biochemistry determinations, including total plasma homocysteine (pHcy), renal function, vitamin status, and polymorphisms of the methylenetetrahydrofolate reductase gene. Results SBI was found in 24.8% of the participants. In the univariate analysis, the pHcy levels in subjects with SBI (13.6±4.1 &mgr;mol/L) were significantly higher (P =0.0004) than those in subjects without SBI (11.0±3.3 &mgr;mol/L). When pHcy levels were stratified into high (≥15.1 mmol/L), moderate (11.6 to 15.0 mmol/L), and low (≤11.5 mmol/L) groups, age (P <0.0001), male sex (P <0.0001), the habits of cigarette smoking (P <0.0001) and of alcohol consumption (P =0.0002), and folate levels (P =0.01) were significantly associated with an elevation of pHcy levels. The elevated pHcy levels were significantly associated with SBI after individual adjustment for age, sex, hypertension, renal function, and the habits of smoking and alcohol consumption. Conclusions pHcy level is associated with age and nutritional and other lifestyle factors, and it contributes to a risk for SBI.

[1]  D. Ducloux,et al.  Homocysteine in cerebral macroangiopathy and microangiopathy , 1999, The Lancet.

[2]  G. Hankey,et al.  Homocysteine and vascular disease , 1999, The Lancet.

[3]  P. Wilson,et al.  The effect of folic acid fortification on plasma folate and total homocysteine concentrations. , 1999, The New England journal of medicine.

[4]  M. Hennerici,et al.  Homocysteine in cerebral macroangiography and microangiopathy , 1999, The Lancet.

[5]  A J Marian,et al.  Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. , 1999, Stroke.

[6]  E. Mori,et al.  Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia. , 1999, Stroke.

[7]  S. Ibayashi,et al.  Decreased plasma tryptophan associated with deep white matter lesions in elderly subjects , 1999, Journal of neurology, neurosurgery, and psychiatry.

[8]  R Clarke,et al.  Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. , 1998, Archives of neurology.

[9]  P. Chiusolo,et al.  Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. , 1998, Blood.

[10]  S. Vollset,et al.  Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. , 1998, The American journal of clinical nutrition.

[11]  I. Alfheim,et al.  Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. , 1998, Clinical chemistry.

[12]  H. Bokura,et al.  Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study , 1998, Journal of Neurology.

[13]  J. Spence,et al.  Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia , 1998, The Lancet.

[14]  H. Bokura,et al.  Subcortical silent brain infarction as a risk factor for clinical stroke. , 1997, Stroke.

[15]  H. Markus,et al.  A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. , 1997, Stroke.

[16]  R. Kronmal,et al.  Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. , 1997, Stroke.

[17]  K. Kario,et al.  'Silent' cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[18]  S. Vollset,et al.  Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. , 1995, JAMA.

[19]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[20]  M. Fujishima,et al.  Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study. , 1995, Stroke.

[21]  M. Matsumoto,et al.  Asymptomatic Carotid Lesions and Silent Cerebral Infarction , 1994, Stroke.

[22]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[23]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[24]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .